Europe
The Board of Directors resolved on a rights issue of 75 MSEK, guaranteed to 80 percent, where the subscription period is ongoing
Alzheimer’s Research UK, the UK’s leading dementia research charity, has welcomed the Labour Party’s manifesto pledge to improve access to future treatments for conditions like dementia.
Healx’s Rare Treatment Accelerator, investing up to the value of $1M in AI and drug discovery resources per selected rare disease project, is now open for applications
Pharma Integrates 2019, which took place on 18th and 19th November, saw over 450 delegates from biotech, pharma, CDMOs and the supply chain come together to debate and share insights on key topics currently affecting the industry.
Progressive degeneration of dopamine-producing nerve cells in the brain leads to dopamine deficiency and ultimately to Parkinson’s disease.
The highly anticipated 25th annual BIO-Europe® international life sciences partnering conference wrapped up in Hamburg, Germany, last week with an all-time high 4,400 attendees from 2,300 companies and 61 countries, engaging in 27,375 one-to-one partnering meetings, a five percent increase over 2018.
As usual, it was a busy week for clinical trial updates. Here’s a look.
The latest approval for Calquence, a Bruton tyrosine kinase inhibitor, was granted under the FDA’s Real-Time Oncology Review and newly established Project Orbis programs.
RSSL has expanded its microbiology capabilities with the launch of a fast, responsive and flexible sterility testing service.
A consortium jointly led by Astorg and Cinven announces that it has signed an agreement to acquire LGC, a global leader in the Life Sciences Tools sector.
PRESS RELEASES